- Home
- Publications
- Publication Search
- Publication Details
Title
Brain NMDA Receptors in Schizophrenia and Depression
Authors
Keywords
-
Journal
Biomolecules
Volume 10, Issue 6, Pages 947
Publisher
MDPI AG
Online
2020-06-23
DOI
10.3390/biom10060947
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intravenous arketamine for treatment-resistant depression: open-label pilot study
- (2020) Gustavo C. Leal et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Less NMDA Receptor Binding in Dorsolateral Prefrontal Cortex and Anterior Cingulate Cortex Associated with Reported Early Life Adversity but Not Suicide
- (2020) Mark D Underwood et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Comparative Pro-cognitive and Neurochemical Profiles of Glycine Modulatory Site Agonists and Glycine Reuptake Inhibitors in the Rat: Potential Relevance to Cognitive Dysfunction and Its Management
- (2020) Kevin C.F. Fone et al. MOLECULAR NEUROBIOLOGY
- Overinhibition mediated by parvalbumin interneurons might contribute to depression-like behavior and working memory impairment induced by lipopolysaccharide challenge
- (2020) Mu-huo Ji et al. BEHAVIOURAL BRAIN RESEARCH
- BDNF deficiency and enriched environment treatment affect neurotransmitter gene expression differently across ages
- (2020) Brittany E. Dong et al. JOURNAL OF NEUROCHEMISTRY
- BNST GluN2D-Containing NMDA Receptors Influence Anxiety- and Depressive-like Behaviors and ModulateCell-Specific Excitatory/Inhibitory Synaptic Balance
- (2020) Gregory J. Salimando et al. JOURNAL OF NEUROSCIENCE
- Regionally selective knockdown of astroglial glutamate transporters in infralimbic cortex induces a depressive phenotype in mice
- (2019) M. Neus Fullana et al. GLIA
- Cortical GABAergic Dysfunction in Stress and Depression: New Insights for Therapeutic Interventions
- (2019) Manoela V. Fogaça et al. Frontiers in Cellular Neuroscience
- Neurobiology of rapid-acting antidepressants: convergent effects on GluA1-synaptic function
- (2019) Ronald S. Duman et al. MOLECULAR PSYCHIATRY
- Cognitive impairment that is induced by (R)-ketamine is abolished in NMDA GluN2D receptor subunit knockout mice
- (2019) Soichiro Ide et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- In vivo electrophysiological recordings of the effects of antidepressant drugs
- (2019) Paul J. Fitzgerald et al. EXPERIMENTAL BRAIN RESEARCH
- Dysfunction in Serotonergic and Noradrenergic Systems and Somatic Symptoms in Psychiatric Disorders
- (2019) Yi Liu et al. Frontiers in Psychiatry
- Role of Serotonin and Noradrenaline in the Rapid Antidepressant Action of Ketamine
- (2019) Xavier López-Gil et al. ACS Chemical Neuroscience
- Markers of glutamate and GABA neurotransmission in the prefrontal cortex of schizophrenia subjects: Disease effects differ across anatomical levels of resolution
- (2019) Samuel J. Dienel et al. SCHIZOPHRENIA RESEARCH
- Novel Treatment for the hardest-to-treat Schizophrenia: Dual Activation of NMDA Receptor and Antioxidant
- (2019) Chieh-Hsin Lin et al. CURRENT DRUG TARGETS
- Defining treatment‐resistant depression
- (2019) Bradley N. Gaynes et al. DEPRESSION AND ANXIETY
- GABA interneurons are the cellular trigger for ketamine’s rapid antidepressant actions
- (2019) Danielle M. Gerhard et al. JOURNAL OF CLINICAL INVESTIGATION
- Prefrontal parvalbumin cells are sensitive to stress and mediate anxiety-related behaviors in female mice
- (2019) Chloe E. Page et al. Scientific Reports
- Voluntary Exercise During Adolescence Mitigated Negative the Effects of Maternal Separation Stress on the Depressive-Like Behaviors of Adult Male Rats: Role of NMDA Receptors
- (2018) Forouzan Fattahi Masrour et al. NEUROCHEMICAL RESEARCH
- The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects
- (2018) Chadi G. Abdallah et al. NEUROPSYCHOPHARMACOLOGY
- Clinical Findings Documenting Cellular and Molecular Abnormalities of Glia in Depressive Disorders
- (2018) Boldizsár Czéh et al. Frontiers in Molecular Neuroscience
- A Deep Learning Approach for Predicting Antidepressant Response in Major Depression Using Clinical and Genetic Biomarkers
- (2018) Eugene Lin et al. Frontiers in Psychiatry
- An astroglial basis of major depressive disorder? An overview
- (2017) Qian Wang et al. GLIA
- Role of NMDA receptor GluN2D subunit in the antidepressant effects of enantiomers of ketamine
- (2017) Soichiro Ide et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Antidepressant Potential of ( R )-Ketamine in Rodent Models: Comparison with ( S )-Ketamine
- (2017) Kenichi Fukumoto et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Restraint stress differentially regulates inflammation and glutamate receptor gene expression in the hippocampus of C57BL/6 and BALB/c mice
- (2017) Monica Sathyanesan et al. STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS
- Schizophrenia and depression, two poles of endocannabinoid system deregulation
- (2017) María Rodríguez-Muñoz et al. Translational Psychiatry
- Chronic Stress Triggers Expression of Immediate Early Genes and Differentially Affects the Expression of AMPA and NMDA Subunits in Dorsal and Ventral Hippocampus of Rats
- (2017) Anibal Pacheco et al. Frontiers in Molecular Neuroscience
- A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression
- (2016) Jaskaran B. Singh et al. AMERICAN JOURNAL OF PSYCHIATRY
- The role of genes involved in stress, neural plasticity, and brain circuitry in depressive phenotypes: Convergent findings in a mouse model of neglect
- (2016) Janitza L. Montalvo-Ortiz et al. BEHAVIOURAL BRAIN RESEARCH
- A quantitative review of the postmortem evidence for decreased cortical N-methyl-d-aspartate receptor expression levels in schizophrenia: How can we link molecular abnormalities to mismatch negativity deficits?
- (2016) Vibeke S. Catts et al. BIOLOGICAL PSYCHOLOGY
- Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder
- (2016) Brittany Jaso et al. Current Neuropharmacology
- Sensitivity of the prefrontal GABAergic system to chronic stress in male and female mice: Relevance for sex differences in stress-related disorders
- (2016) Ryan Shepard et al. NEUROSCIENCE
- Role of calcium, glutamate and NMDA in major depression and therapeutic application
- (2016) Lorenz Deutschenbaur et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Genetic Risk for Schizophrenia: Convergence on Synaptic Pathways Involved in Plasticity
- (2015) Jeremy Hall et al. BIOLOGICAL PSYCHIATRY
- Activation of AMPA Receptors Mediates the Antidepressant Action of Deep Brain Stimulation of the Infralimbic Prefrontal Cortex
- (2015) Laura Jiménez-Sánchez et al. CEREBRAL CORTEX
- Aberrant NMDA receptor DNA methylation detected by epigenome-wide analysis of hippocampus and prefrontal cortex in major depression
- (2015) Oliver Kaut et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Sex differences in glutamate receptor gene expression in major depression and suicide
- (2015) A L Gray et al. MOLECULAR PSYCHIATRY
- The Antidepressant Effects of an mGlu2/3 Receptor Antagonist and Ketamine Require AMPA Receptor Stimulation in the mPFC and Subsequent Activation of the 5-HT Neurons in the DRN
- (2015) Kenichi Fukumoto et al. NEUROPSYCHOPHARMACOLOGY
- Optogenetic stimulation of infralimbic PFC reproduces ketamine’s rapid and sustained antidepressant actions
- (2015) Manabu Fuchikami et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PCP-based mice models of schizophrenia: differential behavioral, neurochemical and cellular effects of acute and subchronic treatments
- (2015) Anna Castañé et al. PSYCHOPHARMACOLOGY
- Adjunctive sarcosine plus benzoate improved cognitive function in chronic schizophrenia patients with constant clinical symptoms: A randomised, double-blind, placebo-controlled trial
- (2015) Chun-Yuan Lin et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Spontaneous Gamma Activity in Schizophrenia
- (2015) Yoji Hirano et al. JAMA Psychiatry
- R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
- (2015) C Yang et al. Translational Psychiatry
- Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in rats
- (2014) Hiroyuki Koike et al. BEHAVIOURAL BRAIN RESEARCH
- Phencyclidine Inhibits the Activity of Thalamic Reticular Gamma-Aminobutyric Acidergic Neurons in Rat Brain
- (2014) Eva Troyano-Rodriguez et al. BIOLOGICAL PSYCHIATRY
- Differential Alterations of Auditory Gamma Oscillatory Responses Between Pre-Onset High-Risk Individuals and First-Episode Schizophrenia
- (2014) Mariko Tada et al. CEREBRAL CORTEX
- Elevated gene expression of glutamate receptors in noradrenergic neurons from the locus coeruleus in major depression
- (2014) Michelle J. Chandley et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Child Abuse, Depression, and Methylation in Genes Involved With Stress, Neural Plasticity, and Brain Circuitry
- (2014) Natalie Weder et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Src kinase as a mediator of convergent molecular abnormalities leading to NMDAR hypoactivity in schizophrenia
- (2014) A Banerjee et al. MOLECULAR PSYCHIATRY
- Reverse Translation of Clinical Electrophysiological Biomarkers in Behaving Rodents under Acute and Chronic NMDA Receptor Antagonism
- (2014) Elyse M Sullivan et al. NEUROPSYCHOPHARMACOLOGY
- The Role of GluN2A and GluN2B Subunits on the Effects of NMDA Receptor Antagonists in Modeling Schizophrenia and Treating Refractory Depression
- (2014) Laura Jiménez-Sánchez et al. NEUROPSYCHOPHARMACOLOGY
- Monoacylglycerol Lipase Inhibition Blocks Chronic Stress-Induced Depressive-Like Behaviors via Activation of mTOR Signaling
- (2014) Peng Zhong et al. NEUROPSYCHOPHARMACOLOGY
- The role of NMDA receptors in the pathophysiology and treatment of mood disorders
- (2014) Mehdi Ghasemi et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Exploring effects of EAAT polymorphisms on cognitive functions in schizophrenia
- (2014) Marco Spangaro et al. PHARMACOGENOMICS
- Optogenetic modulation of descending prefrontocortical inputs to the dorsal raphe bidirectionally bias socioaffective choices after social defeat
- (2014) Collin Challis et al. Frontiers in Behavioral Neuroscience
- GluN2B-containing NMDA receptors regulate depression-like behavior and are critical for the rapid antidepressant actions of ketamine
- (2014) Oliver H Miller et al. eLife
- The R-Stereoisomer of Ketamine as an Alternative for Ketamine for Treatment-resistant Major Depression
- (2014) Kenji Hashimoto Clinical Psychopharmacology and Neuroscience
- From Pathophysiology to Novel Antidepressant Drugs: Glial Contributions to the Pathology and Treatment of Mood Disorders
- (2013) Gerard Sanacora et al. BIOLOGICAL PSYCHIATRY
- Impact of Ketamine on Neuronal Network Dynamics: Translational Modeling of Schizophrenia-Relevant Deficits
- (2013) Bernat Kocsis et al. CNS Neuroscience & Therapeutics
- Astrocyte Pathology in Major Depressive Disorder: Insights from Human Postmortem Brain Tissue
- (2013) Grazyna Rajkowska et al. CURRENT DRUG TARGETS
- Acute and chronic effects of NMDA receptor antagonists in rodents, relevance to negative symptoms of schizophrenia: A translational link to humans
- (2013) Joanna C. Neill et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- A review of ketamine in affective disorders: Current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action
- (2013) Marie Naughton et al. JOURNAL OF AFFECTIVE DISORDERS
- Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder
- (2013) Mark J. Niciu et al. JOURNAL OF NEURAL TRANSMISSION
- Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacy with minimal psychotomimetic adverse effects
- (2013) G Sanacora et al. MOLECULAR PSYCHIATRY
- Glycine transporters as novel therapeutic targets in schizophrenia, alcohol dependence and pain
- (2013) Robert J. Harvey et al. NATURE REVIEWS DRUG DISCOVERY
- GLYX-13, a NMDA Receptor Glycine-Site Functional Partial Agonist, Induces Antidepressant-Like Effects Without Ketamine-Like Side Effects
- (2013) Jeffrey Burgdorf et al. NEUROPSYCHOPHARMACOLOGY
- Effect of treadmill exercise on the BDNF-mediated pathway in the hippocampus of stressed rats
- (2013) Zheng Huan Fang et al. NEUROSCIENCE RESEARCH
- R (−)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine
- (2013) Ji-chun Zhang et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- A study of N-methyl-D-aspartate receptor gene (GRIN2B) variants as predictors of treatment-resistant major depression
- (2013) Chen Zhang et al. PSYCHOPHARMACOLOGY
- Antidepressant effects of AMPA and ketamine combination: role of hippocampal BDNF, synapsin, and mTOR
- (2013) Luli Akinfiresoye et al. PSYCHOPHARMACOLOGY
- Mechanisms of Gamma Oscillations
- (2012) György Buzsáki et al. Annual Review of Neuroscience
- Reduced Glutamate Decarboxylase 65 Protein Within Primary Auditory Cortex Inhibitory Boutons in Schizophrenia
- (2012) Caitlin E. Moyer et al. BIOLOGICAL PSYCHIATRY
- A Randomized Trial of a Low-Trapping Nonselective N-Methyl-D-Aspartate Channel Blocker in Major Depression
- (2012) Carlos A. Zarate et al. BIOLOGICAL PSYCHIATRY
- Linking Microcircuit Dysfunction to Cognitive Impairment: Effects of Disinhibition Associated with Schizophrenia in a Cortical Working Memory Model
- (2012) J. D. Murray et al. CEREBRAL CORTEX
- Female Early Adult Depression Results in Detrimental Impacts on the Behavioral Performance and Brain Development in Offspring
- (2012) Yu Gong et al. CNS Neuroscience & Therapeutics
- Targeting the Glutamatergic System to Treat Major Depressive Disorder
- (2012) Daniel C. Mathews et al. DRUGS
- A Randomized, Placebo-Controlled, Crossover Pilot Trial of the Oral Selective NR2B Antagonist MK-0657 in Patients With Treatment-Resistant Major Depressive Disorder
- (2012) Lobna Ibrahim et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Hippocampal volume and total cell numbers in major depressive disorder
- (2012) Justin A. Cobb et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Glutamate-based depression GBD
- (2012) Dennis J. McCarthy et al. MEDICAL HYPOTHESES
- Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia
- (2012) C S Weickert et al. MOLECULAR PSYCHIATRY
- A prefrontal cortex–brainstem neuronal projection that controls response to behavioural challenge
- (2012) Melissa R. Warden et al. NATURE
- Stress-Induced Changes of Hippocampal NMDA Receptors: Modulation by Duloxetine Treatment
- (2012) Francesca Calabrese et al. PLoS One
- Reduced phosphorylation of the mTOR signaling pathway components in the amygdala of rats exposed to chronic stress
- (2012) Agata Chandran et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression
- (2011) Hiroyuki Koike et al. BEHAVIOURAL BRAIN RESEARCH
- Differential Role of NR2A and NR2B Subunits in N-Methyl-D-Aspartate Receptor Antagonist-Induced Aberrant Cortical Gamma Oscillations
- (2011) Bernat Kocsis BIOLOGICAL PSYCHIATRY
- Gamma oscillations in schizophrenia: Mechanisms and clinical significance
- (2011) Yinming Sun et al. BRAIN RESEARCH
- Importance of inter-hemispheric prefrontal connection in the effects of non-competitive NMDA receptor antagonists
- (2011) Xavier López-Gil et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Mouse strain differences in phencyclidine-induced behavioural changes
- (2011) Akihiro Mouri et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Stressor-induced NMDAR dysfunction as a unifying hypothesis for the aetiology, pathogenesis and comorbidity of clinical depression
- (2011) W.N. Marsden MEDICAL HYPOTHESES
- NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
- (2011) Anita E. Autry et al. NATURE
- Dopamine induces a GluN2A-dependent form of long-term depression of NMDA synaptic responses in the nucleus accumbens
- (2011) Karima Chergui NEUROPHARMACOLOGY
- From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment
- (2011) Bita Moghaddam et al. NEUROPSYCHOPHARMACOLOGY
- The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder
- (2011) Courtney S. Jernigan et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Is the Acute NMDA Receptor Hypofunction a Valid Model of Schizophrenia?
- (2011) A. Adell et al. SCHIZOPHRENIA BULLETIN
- Taming the Ketamine Tiger
- (2010) Edward F. Domino ANESTHESIOLOGY
- Assessment of auditory sensory processing in a neurodevelopmental animal model of schizophrenia—Gating of auditory-evoked potentials and prepulse inhibition
- (2010) Brian Villumsen Broberg et al. BEHAVIOURAL BRAIN RESEARCH
- Unraveling Monoamine Receptors Involved in the Action of Typical and Atypical Antipsychotics on Glutamatergic and Serotonergic Transmission in Prefrontal Cortex
- (2010) Xavier Lopez-Gil et al. CURRENT PHARMACEUTICAL DESIGN
- Chronic stress and impaired glutamate function elicit a depressive-like phenotype and common changes in gene expression in the mouse frontal cortex
- (2010) R.M. Tordera et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Role of the mTOR signaling pathway in the rapid antidepressant action of ketamine
- (2010) Kenji Hashimoto Expert Review of Neurotherapeutics
- Mammalian Target of Rapamycin (mTOR) Activation Increases Axonal Growth Capacity of Injured Peripheral Nerves
- (2010) Namiko Abe et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder
- (2010) Nancy DiazGranados et al. JOURNAL OF CLINICAL PSYCHIATRY
- Antidepressant Effect of Optogenetic Stimulation of the Medial Prefrontal Cortex
- (2010) H. E. Covington et al. JOURNAL OF NEUROSCIENCE
- Abnormal neural oscillations and synchrony in schizophrenia
- (2010) Peter J. Uhlhaas et al. NATURE REVIEWS NEUROSCIENCE
- Glutamate Receptor Ion Channels: Structure, Regulation, and Function
- (2010) S. F. Traynelis et al. PHARMACOLOGICAL REVIEWS
- Dissociation of acute and chronic intermittent phencyclidine-induced performance deficits in the 5-choice serial reaction time task: influence of clozapine
- (2010) David M. Thomson et al. PSYCHOPHARMACOLOGY
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
- (2010) N. Li et al. SCIENCE
- A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptors
- (2010) Praseeda Mullasseril et al. Nature Communications
- Gamma Oscillation Deficits and the Onset and Early Progression of Schizophrenia
- (2010) Tsung-Ung W. Woo et al. HARVARD REVIEW OF PSYCHIATRY
- Ketamine Modulates Theta and Gamma Oscillations
- (2009) Maciej T. Lazarewicz et al. JOURNAL OF COGNITIVE NEUROSCIENCE
- Parvalbumin neurons and gamma rhythms enhance cortical circuit performance
- (2009) Vikaas S. Sohal et al. NATURE
- Driving fast-spiking cells induces gamma rhythm and controls sensory responses
- (2009) Jessica A. Cardin et al. NATURE
- Gamma and Delta Neural Oscillations and Association with Clinical Symptoms under Subanesthetic Ketamine
- (2009) L Elliot Hong et al. NEUROPSYCHOPHARMACOLOGY
- NMDA Receptor Hypofunction Leads to Generalized and Persistent Aberrant γ Oscillations Independent of Hyperlocomotion and the State of Consciousness
- (2009) Tahir Hakami et al. PLoS One
- Steady State Responses: Electrophysiological Assessment of Sensory Function in Schizophrenia
- (2009) C. A. Brenner et al. SCHIZOPHRENIA BULLETIN
- Glutamate-based antidepressants: 20 years on
- (2009) Phil Skolnick et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Loss of Glial Glutamate and Aspartate Transporter (Excitatory Amino Acid Transporter 1) Causes Locomotor Hyperactivity and Exaggerated Responses to Psychotomimetics: Rescue by Haloperidol and Metabotropic Glutamate 2/3 Agonist
- (2008) Rose-Marie Karlsson et al. BIOLOGICAL PSYCHIATRY
- Glial Loss in the Prefrontal Cortex Is Sufficient to Induce Depressive-like Behaviors
- (2008) Mounira Banasr et al. BIOLOGICAL PSYCHIATRY
- Elevated levels of NR2A and PSD-95 in the lateral amygdala in depression
- (2008) Beata Karolewicz et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Role of different monoamine receptors controlling MK-801-induced release of serotonin and glutamate in the medial prefrontal cortex: relevance for antipsychotic action
- (2008) Xavier López-Gil et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder
- (2008) Sheldon H. Preskorn et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- NMDA receptors in clinical neurology: excitatory times ahead
- (2008) Lorraine V Kalia et al. LANCET NEUROLOGY
- Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole
- (2008) M Banasr et al. MOLECULAR PSYCHIATRY
- Rules of engagement for NMDA receptor subunits
- (2008) M. H. Ulbrich et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression
- (2008) Anteneh M. Feyissa et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats
- (2008) Alice Egerton et al. PSYCHOPHARMACOLOGY
- Relationship between ketamine-induced psychotic symptoms and NMDA receptor occupancy—a [123I]CNS-1261 SPET study
- (2008) James M. Stone et al. PSYCHOPHARMACOLOGY
- GABA Neurons and the Mechanisms of Network Oscillations: Implications for Understanding Cortical Dysfunction in Schizophrenia
- (2008) G. Gonzalez-Burgos et al. SCHIZOPHRENIA BULLETIN
- Abnormal expression of glutamate transporter and transporter interacting molecules in prefrontal cortex in elderly patients with schizophrenia
- (2008) Deborah Bauer et al. SCHIZOPHRENIA RESEARCH
- N-Methyl d-Aspartate Receptor Antagonists Ketamine and MK-801 Induce Wake-Related Aberrant γ Oscillations in the Rat Neocortex
- (2007) Didier Pinault BIOLOGICAL PSYCHIATRY
- Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors
- (2007) Sungho Maeng et al. BIOLOGICAL PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More